Biomarker for detecting fanconi anemia and detecting kit
A biomarker and kit technology, applied in the field of molecular biology, can solve the problems of limitations, low detection efficiency and accuracy, and achieve high detection rate and high detection efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Example 1 Screening of Fanconi Anemia Mutation Gene Group in Chinese Population
[0041] Materials and methods: Among the patients diagnosed from May 2018 to August 2018 in Hematology Hospital of Chinese Academy of Medical Sciences and Union Medical Diagnostic Center, according to the following criteria, we conducted continuous enrollment (12 patients).
[0042] Inclusion criteria: patients with pancytopenia and suspected Fanconi anemia after clinical symptoms and relevant laboratory tests, and clinicians need to perform genetic testing to confirm whether it is Fanconi anemia. The diagnostic results of the 12 patients are shown in Table 3.
[0043] Table 3 List of patient diagnosis results
[0044]
[0045]
[0046] Extraction of DNA to be tested: 3 mL of peripheral blood was collected from patients to extract genomic DNA for testing, which was approved by the Ethics Committee of the Hematology Hospital, Chinese Academy of Medical Sciences.
[0047] Sample process...
Embodiment 2
[0060] The primers required for the synthetic detection kit of embodiment 2
[0061] Primer design: for the mutation site described in the present invention, use the Primer6.0 software to design multiple PCR primers required for amplification, and finally find that the composite amplification primer sequence shown in Table 2 can achieve a balanced or complete amplification result, All mutation sites are amplified with relatively close efficiency.
[0062] Primer synthesis: send the designed primers to the synthesis company for synthesis.
Embodiment 3
[0063] Example 3 Utilize the kit described in Example 2 to detect Fanconi anemia patient samples
[0064] Collect 3mL of the peripheral blood of the patient described in Example 1, extract genomic DNA, use the genomic DNA stock solution containing the mutant gene sequence in the mutant gene group described in the present invention as a positive control, and use the DNA derived from a healthy person that does not contain the mutant gene after confirmation. The genomic DNA sequence storage solution of the sequence was used as a negative control; sample processing, library construction, template preparation and sequencing reactions were the same as in Example 1. The positive rates of 19 genes detected in 12 patients are shown in Table 4 below.
[0065] Table 4 List of positive rates of 19 genes
[0066] mutant gene
[0067] After statistics, it was shown that 3 of the 12 patients were detected as Fanconi anemia (all in line with compound heterozygous mutations), and the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com